Universal Biosensors Inc (UBI) - Net Assets

Latest as of June 2025: AU$7.08 Million AUD ≈ $5.01 Million USD

Based on the latest financial reports, Universal Biosensors Inc (UBI) has net assets worth AU$7.08 Million AUD (≈ $5.01 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$14.94 Million ≈ $10.57 Million USD) and total liabilities (AU$7.86 Million ≈ $5.56 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check asset resilience ratio of Universal Biosensors Inc to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets AU$7.08 Million
% of Total Assets 47.38%
Annual Growth Rate 12.28%
5-Year Change -54.26%
10-Year Change 31.05%
Growth Volatility 188.81

Universal Biosensors Inc - Net Assets Trend (2002–2024)

This chart illustrates how Universal Biosensors Inc's net assets have evolved over time, based on quarterly financial data. Also explore Universal Biosensors Inc assets under control for the complete picture of this company's asset base.

Annual Net Assets for Universal Biosensors Inc (2002–2024)

The table below shows the annual net assets of Universal Biosensors Inc from 2002 to 2024. For live valuation and market cap data, see Universal Biosensors Inc stock valuation.

Year Net Assets Change
2024-12-31 AU$17.37 Million
≈ $12.29 Million		 -10.95%
2023-12-31 AU$19.51 Million
≈ $13.80 Million		 -25.23%
2022-12-31 AU$26.09 Million
≈ $18.46 Million		 -5.49%
2021-12-31 AU$27.61 Million
≈ $19.53 Million		 -27.30%
2020-12-31 AU$37.98 Million
≈ $26.87 Million		 -16.34%
2019-12-31 AU$45.39 Million
≈ $32.12 Million		 -10.42%
2018-12-31 AU$50.67 Million
≈ $35.85 Million		 +296.84%
2017-12-31 AU$12.77 Million
≈ $9.04 Million		 -3.66%
2016-12-31 AU$13.25 Million
≈ $9.38 Million		 -0.01%
2015-12-31 AU$13.26 Million
≈ $9.38 Million		 -32.85%
2014-12-31 AU$19.74 Million
≈ $13.97 Million		 -33.50%
2013-12-31 AU$29.68 Million
≈ $21.00 Million		 -24.61%
2012-12-31 AU$39.37 Million
≈ $27.86 Million		 +12.42%
2011-12-31 AU$35.02 Million
≈ $24.78 Million		 -25.83%
2010-12-31 AU$47.22 Million
≈ $33.41 Million		 -7.98%
2009-12-31 AU$51.31 Million
≈ $36.31 Million		 +5.36%
2008-12-31 AU$48.70 Million
≈ $34.46 Million		 -18.93%
2007-12-31 AU$60.07 Million
≈ $42.51 Million		 +62.16%
2006-12-31 AU$37.05 Million
≈ $26.21 Million		 +841.95%
2005-12-31 AU$3.93 Million
≈ $2.78 Million		 -1.01%
2004-12-31 AU$3.97 Million
≈ $2.81 Million		 -2.46%
2003-12-31 AU$4.07 Million
≈ $2.88 Million		 +199.49%
2002-12-31 AU$1.36 Million
≈ $962.29K		 --

Equity Component Analysis

This analysis shows how different components contribute to Universal Biosensors Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 222962.9% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock AU$29.81K 0.17%
Other Comprehensive Income AU$-345.32K -1.99%
Other Components AU$131.35 Million 756.11%
Total Equity AU$17.37 Million 100.00%

Universal Biosensors Inc Competitors by Market Cap

The table below lists competitors of Universal Biosensors Inc ranked by their market capitalization.

Company Market Cap
8I Holdings Ltd
AU:8IH
 $2.96 Million
MacDonald Mines Exploration Ltd
V:BMK
 $2.96 Million
Next 15 Group PLC
LSE:NFG
 $2.96 Million
Antler Gold Inc
V:ANTL
 $2.96 Million
Colabor Group Inc.
TO:GCL
 $2.95 Million
Timah Resources Ltd
AU:TML
 $2.95 Million
Constellation Technologies Ltd
AU:CT1
 $2.95 Million
Eguana Technologies Inc
V:EGT
 $2.94 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Universal Biosensors Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 19,507,809 to 17,371,433, a change of -2,136,376 (-11.0%).
  • Net loss of 14,239,743 reduced equity.
  • Share repurchases of 12,015,280 reduced equity.
  • New share issuances of 12,015,280 increased equity.
  • Other comprehensive income decreased equity by 13,155.
  • Other factors increased equity by 12,116,522.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income AU$-14.24 Million -81.97%
Share Repurchases AU$12.02 Million -69.17%
Share Issuances AU$12.02 Million +69.17%
Other Comprehensive Income AU$-13.15K -0.08%
Other Changes AU$12.12 Million +69.75%
Total Change AU$- -10.95%

Book Value vs Market Value Analysis

This analysis compares Universal Biosensors Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.22x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has increased from 0.05x to 0.22x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2006-12-31 AU$0.29 AU$0.01 x
2007-12-31 AU$0.46 AU$0.01 x
2008-12-31 AU$0.31 AU$0.01 x
2009-12-31 AU$0.32 AU$0.01 x
2010-12-31 AU$0.30 AU$0.01 x
2011-12-31 AU$0.22 AU$0.01 x
2012-12-31 AU$0.25 AU$0.01 x
2013-12-31 AU$0.17 AU$0.01 x
2014-12-31 AU$0.11 AU$0.01 x
2015-12-31 AU$0.08 AU$0.01 x
2016-12-31 AU$0.07 AU$0.01 x
2017-12-31 AU$0.07 AU$0.01 x
2018-12-31 AU$0.29 AU$0.01 x
2019-12-31 AU$0.26 AU$0.01 x
2020-12-31 AU$0.21 AU$0.01 x
2021-12-31 AU$0.16 AU$0.01 x
2022-12-31 AU$0.13 AU$0.01 x
2023-12-31 AU$0.09 AU$0.01 x
2024-12-31 AU$0.06 AU$0.01 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Universal Biosensors Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -81.97%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -226.65%
  • • Asset Turnover: 0.24x
  • • Equity Multiplier: 1.49x
  • Recent ROE (-81.97%) is below the historical average (-24.68%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2006 -7.95% -110.95% 0.07x 1.08x AU$-6.65 Million
2007 -14.00% -649.93% 0.02x 1.06x AU$-14.41 Million
2008 -24.63% -263.23% 0.08x 1.12x AU$-16.87 Million
2009 2.79% 6.49% 0.39x 1.09x AU$-3.70 Million
2010 -14.00% -36.36% 0.34x 1.14x AU$-11.33 Million
2011 -41.95% -99.97% 0.33x 1.29x AU$-18.19 Million
2012 -23.19% -30.80% 0.60x 1.25x AU$-13.07 Million
2013 -39.19% -77.10% 0.28x 1.84x AU$-14.60 Million
2014 -47.19% -97.76% 0.20x 2.41x AU$-11.29 Million
2015 -49.61% -39.20% 0.37x 3.39x AU$-7.90 Million
2016 9.43% 6.64% 0.38x 3.77x AU$-75.15K
2017 -5.99% -3.04% 0.54x 3.62x AU$-2.04 Million
2018 74.13% 54.08% 0.99x 1.38x AU$32.50 Million
2019 -10.68% -70.26% 0.11x 1.38x AU$-9.39 Million
2020 -20.19% -239.40% 0.06x 1.48x AU$-11.46 Million
2021 -37.31% -178.30% 0.13x 1.61x AU$-13.06 Million
2022 -102.92% -593.48% 0.10x 1.77x AU$-29.46 Million
2023 -34.56% -101.64% 0.22x 1.54x AU$-8.69 Million
2024 -81.97% -226.65% 0.24x 1.49x AU$-15.98 Million

Industry Comparison

This section compares Universal Biosensors Inc's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $61,040,828
  • Average return on equity (ROE) among peers: -33.85%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Universal Biosensors Inc (UBI) AU$7.08 Million -7.95% 1.11x $2.95 Million
4DMEDICAL Ltd (4DX) $64.24 Million -46.81% 0.48x $1.63 Billion
Adherium Ltd (ADR) $-4.76 Million 0.00% 0.00x $7.37 Million
Aroa Biosurgery Ltd (ARX) $6.92 Million -23.35% 0.08x $150.91 Million
Atomo Diagnostics Ltd (AT1) $-5.47 Million 0.00% 0.00x $13.76 Million
Avita Medical Inc (AVH) $5.12 Million -224.74% 0.50x $132.15 Million
Anteris Technologies Global Corp (AVR) $22.64 Million -106.07% 0.18x $570.83 Million
Control Bionics Ltd (CBL) $5.05 Million -38.22% 0.07x $18.95 Million
Cardiex Ltd (CDX) $4.88 Million 56.04% 0.31x $13.23 Million
Compumedics Ltd (CMP) $8.51 Million 8.89% 1.37x $41.70 Million
Cochlear Ltd (COH) $503.28 Million 35.79% 0.47x $4.60 Billion

About Universal Biosensors Inc

AU:UBI Australia Medical Devices
Market Cap
$2.95 Million
AU$4.17 Million AUD
Market Cap Rank
#29228 Global
#1704 in Australia
Share Price
AU$0.01
Change (1 day)
+0.00%
52-Week Range
AU$0.01 - AU$0.05
All Time High
AU$1.00
Categories
Companies in Australia Medical Devices
About

Universal Biosensors, Inc., through its subsidiaries, designs and develops electrochemical cells (strips) used in conjunction with point-of-use devices in Australia, the Americas, Europe, and internationally. The company manufactures and distributes Prothrombin Time International Normalized Ratio coagulation test strips and Xprecia Stride and Xprecia Prime medical devices to monitor the effect of… Read more